Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors

BACKGROUNDS/AIMS: The protective effect of everolimus (EVR) in hepatocellular carcinoma (HCC) patients who receive liver transplantation in terms of reducing the recurrence has not been sufficiently investigated in clinical trials. In this second stage of our ongoing study, we intend to analyze the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ann Hepatobiliary Pancreat Surg
Autori principali: Thorat, Ashok, Jeng, Long-Bin, Yang, Horng-Ren, Yeh, Chun-Chieh, Hsu, Shih-Chao, Chen, Te-Hung, Poon, Kin-Shing
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Association of Hepato-Biliary-Pancreatic Surgery 2017
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5736740/
https://ncbi.nlm.nih.gov/pubmed/29264583
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14701/ahbps.2017.21.4.205
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi